Waning immunity and subclinical measles infections in England

被引:36
作者
Glass, K [1 ]
Grenfell, BT
机构
[1] Australian Natl Univ, Natl Ctr Epidemiol Populat Hlth, Canberra, ACT 0200, Australia
[2] Univ Cambridge, Dept Zool, Cambridge CB2 3EJ, England
基金
英国惠康基金; 英国医学研究理事会;
关键词
measles; waning immunity; mathematical model;
D O I
10.1016/j.vaccine.2004.02.047
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Following the introduction of vaccination against measles, levels of clinical infection have dropped markedly. As we move further into the vaccine era, increasingly many individuals owe their measles immunity to vaccination and have had few (if any) exposures to wild virus. A number of recent reports suggest that vaccinated individuals with low levels of immunity may be at risk of subclinical measles infection. We explore the interplay between levels of infection and immunity over time using a mathematical model that simulates infection, waning and boosting of immunity. We focus particularly on the situation in England, where vaccination has been in place since 1966. Simulations of our model demonstrate a rise in the levels of subclinical measles infection over time, and a corresponding rise in clinical measles infections if vaccination levels are too low. We compare the impact of intervention strategies, and find that the rise in cases is most effectively reduced by 'catch-up' vaccination of children. In recent years, vaccination levels in England have dropped from above 90% in the 1990s to 84% in 2001/2002. We discuss the impact of declining vaccination levels on clinical and subclinical infections. (C) 2004 Elsevier Ltd. All rights reserved.
引用
收藏
页码:4110 / 4116
页数:7
相关论文
共 45 条
  • [21] Characteristics of asymptomatic secondary immune responses to measles virus in late convalescent donors
    Huiss, S
    Damien, B
    Schneider, F
    Muller, CP
    [J]. CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 1997, 109 (03) : 416 - 420
  • [22] Immunity against measles in populations of women and infants in Poland
    Janaszek, W
    Slusarczyk, J
    [J]. VACCINE, 2003, 21 (21-22) : 2948 - 2953
  • [23] Measles vaccine efficacy during an epidemic in 1998 in the highly vaccinated population of Poland
    Janaszek, W
    Gay, NJ
    Gut, W
    [J]. VACCINE, 2003, 21 (5-6) : 473 - 478
  • [24] Measles outbreaks in a population with declining vaccine uptake
    Jansen, VAA
    Stollenwerk, N
    Jensen, HJ
    Ramsay, ME
    Edmunds, WJ
    Rhodes, CJ
    [J]. SCIENCE, 2003, 301 (5634) : 804 - 804
  • [25] MEASLES, MUMPS, AND RUBELLA ANTIBODIES IN VACCINATED BALTIMORE CHILDREN
    KING, JC
    LICHENSTEIN, R
    FEIGELMAN, S
    LUNA, C
    PERMUTT, TJ
    PATEL, J
    [J]. AMERICAN JOURNAL OF DISEASES OF CHILDREN, 1993, 147 (05): : 558 - 560
  • [26] Measles seroepidemiology and decay rate of vaccine-induced measles IgG titers in Taiwan, 1995-1997
    Lee, MS
    Chien, LJ
    Yueh, YY
    Lu, CF
    [J]. VACCINE, 2001, 19 (32) : 4644 - 4651
  • [27] RECURRENT OUTBREAKS OF MEASLES, CHICKENPOX AND MUMPS .1. SEASONAL-VARIATION IN CONTACT RATES
    LONDON, WP
    YORKE, JA
    [J]. AMERICAN JOURNAL OF EPIDEMIOLOGY, 1973, 98 (06) : 453 - 468
  • [28] DURATION OF LIVE MEASLES VACCINE-INDUCED IMMUNITY
    MARKOWITZ, LE
    PREBLUD, SR
    FINE, PEM
    ORENSTEIN, WA
    [J]. PEDIATRIC INFECTIOUS DISEASE JOURNAL, 1990, 9 (02) : 101 - 110
  • [29] Mossong J, 1999, AM J EPIDEMIOL, V150, P1238, DOI 10.1093/oxfordjournals.aje.a009951
  • [30] Modelling antibody response to measles vaccine and subsequent waning of immunity in a low exposure population
    Mossong, J
    O'Callaghan, CJ
    Ratnam, S
    [J]. VACCINE, 2000, 19 (4-5) : 523 - 529